MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABVC — ABVC BioPharma, Inc. Common Stock
NasdaqABVC BioPharma, Inc. Common Stock
$1.02
-0.04(-3.77%)
- O
- 1.07
- H
- 1.08
- L
- 1.02
- V
- 100.14K
⏱️ End-of-day dataAs of Oct 1, 2026
ABVC — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 140,324.00 | 681,480.00 | 192,068.00 | 388,251.00 | 152,206.00 | 248,382.00 |
| Other Short Term Investments | 62,185.00 | 64,354.00 | 65,175.00 | 65,211.00 | 65,052.00 | 64,736.00 |
| Restricted Cash | 0.00 | 645,505.00 | 661,843.00 | 688,075.00 | 607,362.00 | 615,433.00 |
| Other Current Assets | 250,017.00 | 346,616.00 | 447,280.00 | 194,999.00 | 96,362.00 | 96,213.00 |
| Total Current Assets | 648,848.00 | $2.50M | $4.07M | $2.77M | $1.47M | $2.18M |
| Properties | $1.83M | $1.91M | 369,135.00 | 459,325.00 | 533,460.00 | 640,387.00 |
| Land And Improvements | $12.68M | $12.69M | $11.90M | $8.05M | $8.00M | 338,966.00 |
| Machinery Furniture Equipment | $1.30M | $1.31M | $1.31M | $1.33M | $1.29M | $1.29M |
| Accumulated Depreciation | $-3.38M | $-3.38M | $-3.38M | $-3.39M | $-3.34M | $-3.34M |
| Investments And Advances | $1.85M | $1.88M | $2.75M | $2.84M | $2.76M | $2.26M |
| Other Non Current Assets | 106,417.00 | 116,966.00 | 117,017.00 | 141,304.00 | 127,128.00 | 133,121.00 |
| Total Non Current Assets | $19.08M | $18.56M | $17.10M | $13.47M | $13.41M | $5.36M |
| Total Assets | $19.73M | $21.06M | $21.18M | $16.24M | $14.88M | $7.54M |
| Accrued Expenses | $2.24M | $2.25M | $2.27M | $2.57M | $2.03M | $2.06M |
| Short Term Debt | $1.22M | $1.87M | $1.23M | $1.41M | $2.00M | $2.19M |
| Deferred Revenue | 12,600.00 | 12,600.00 | 81,115.00 | 81,115.00 | 81,115.00 | 81,115.00 |
| Tax Payable | 5,888.00 | 11,964.00 | 6,170.00 | 23,521.00 | N/A | 0.00 |
| Pensions | $1.39M | $1.45M | $1.15M | $1.16M | $1.13M | $1.15M |
| Other Current Liabilities | 523,853.00 | 470,133.00 | 575,578.00 | 564,132.00 | 617,879.00 | 302,274.00 |
| Total Current Liabilities | $5.39M | $6.16M | $6.51M | $6.53M | $6.68M | $6.56M |
| Long Term Debt | $1.51M | $1.60M | 164,072.00 | 177,133.00 | 166,985.00 | 236,807.00 |
| Total Non Current Liabilities | $1.51M | $1.60M | 176,072.00 | 218,813.00 | 238,665.00 | 258,487.00 |
| Total Liabilities | $6.90M | $7.76M | $6.68M | $6.75M | $6.92M | $6.82M |
| Common Stock | 25,767.00 | 25,053.00 | 24,190.00 | 19,533.00 | 15,378.00 | 13,868.00 |
| Retained Earnings | $-78.42M | $-76.86M | $-73.30M | $-72.05M | $-69.79M | $-68.95M |
| Other Shareholders Equity | 499,650.00 | 487,602.00 | 487,048.00 | 483,812.00 | 444,172.00 | 445,665.00 |
| Total Shareholders Equity | $12.83M | $13.30M | $14.49M | $9.49M | $7.96M | 723,959.00 |
| Additional Paid In Capital | $97.15M | $96.01M | $93.11M | $86.38M | $83.62M | $78.60M |
| Treasury Stock | $8.91M | $8.91M | $8.91M | $8.91M | $8.91M | $8.91M |
| Minority Interest | $2.06M | $2.19M | $2.44M | $2.48M | $2.55M | -502,181.00 |
| Inventory | N/A | N/A | 11,460.00 | 11,460.00 | 11,460.00 | N/A |
| Other Non Current Liabilities | N/A | N/A | 12,000.00 | 41,680.00 | 71,680.00 | 21,680.00 |
| Construction In Progress | N/A | N/A | N/A | N/A | 691,900.00 | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | 0.00 |